30 August
Completion of the first preclinical pilot study in project PB001, in which Pure Biologics is developing a novel immunotherapy for the treatment of colorectal cancer.
Menu Close

We use cookies to give you the best browsing experience, site traffic analysis, and advertisement management.

Pure Biologics - Harnessing the power of antibodies and aptamers